Aldeyra Therapeutics announced its clinical development strategy aimed at the resubmission of a New ...
read moreProvectus Biopharmaceuticals has signed an exclusive global licensing agreement with the University ...
read moreFrom April 5 to 8, 2024, the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meet...
read moreABVC BioPharma, Inc. has entered into a significant global licensing agreement with ForSeeCon Eye Co...
read moreIveric Bio has received permanent J-code from CMS for its GA treatment, Izervay (avacincaptad pegol ...
read moreRayner announced a significant update to its packaging, marking a pivotal step towards achieving its...
read moreBlueRock Therapeutics announced a collaboration to introduce a new cohort to the Foundation's 'Uni-R...
read moreNanodropper Inc announced that the results from a clinical trial evaluating the NanodropperĀ® Adaptor...
read moreLenz Therapeutics has officially completed its merger with Graphite Bio, paving the way for the newl...
read moreNicox SA announced the results of its pivotal Mont Blanc Phase 3 trial, which compared the efficacy ...
read more